Advanced search
Publication Cover
Modern Rheumatology Volume 24, 2014 - Issue 6
Journal homepage
248
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Analysis of various factors on the relapse of acute neurological attacks in Behçet's disease

Shunsei HirohataDepartment of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Sagamihara, Kanagawa, JapanCorrespondence[email protected]
,
Hirotoshi KikuchiDepartment of Microbiology and Immunology, Teikyo University School of Medicine, Itabashi, Tokyo, Japan
,
Tetsuji SawadaDepartment of Internal Medicine 3, Tokyo Medical University, Shinjuku, Tokyo, Japan
,
Hiroko NagafuchiDepartment of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan
,
Masataka KuwanaDepartment of Internal Medicine, Keio University School of Medicine, Shinjuku, Tokyo, Japan
,
Mitsuhiro TakenoDepartment of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan
&
Yoshiaki IshigatsuboDepartment of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan
 show all
Pages 961-965 | Received 06 Dec 2013, Accepted 04 Feb 2014, Published online: 19 Mar 2014

References

  • Hirohata S, Kikuchi H. Behçet's disease. Arthritis Res Ther. 2003;5(3):139–46.
  • Serdaroglu P. Behçet's disease and the nervous system. J Neurol. 1998;245(4):197–205.
  • Kidd D, Steuer A, Denman AM, Rudge P. Neurological complications in Behçet's syndrome. Brain. 1999;122(Pt 11):2183–94.
  • Siva A, Altintas A, Saip S. Behçet's syndrome and the nervous system. Curr Opin Neurol. 2004;17(3):347–57.
  • Akman-Demir G, Serdaroglu P, Tasci B. The Neuro-Behçet Study Group. Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. Brain. 1999;122(Pt 11):2171–82.
  • Hirohata S, Isshi K, Oguchi H, Ohse T, Haraoka H, Takeuchi A, Hashimoto T. Cerebrospinal fluid interleukin-6 in progressive Neuro-Behcet's syndrome. Clin Immunol Immunopathol. 1997; 82(1):12–7.
  • Hirohata S. Potential new therapeutic options for involvement of central nervous system in Behçet's disease (Neuro-Behçet's syndrome). Curr Rheumatol Rev 2007;3(4):297–303.
  • Siva A, Hirohata S. Behçet's syndrome and the nervous. In: Yazici Y, Yazici H, editors. Behçet's syndrome. New York: Springer; 2010, pp. 95–113.
  • Kotake S, Higashi K, Yoshikawa K, Sasamoto Y, Okamoto T, Matsuda H. Central nervous system symptoms in patients with Behçet disease receiving cyclosporine therapy. Ophthalmology. 1999;106(3):586–9.
  • Hirohata S, Kikuchi H, Sawada T, Nagafuchi H, Kuwana M, Takeno M, et al. Clinical characteristics of neuro-Behcet's disease in Japan: a multicenter retrospective analysis. Mod Rheumatol. 2012;22(3):405–13.
  • International Study Group for Behcet's disease. Criteria for diagnosis of Behcet's disease. Lancet. 1990;335(8697):1078–80.
  • Kato Y, Numaga J, Kato S, Kaburaki T, Kawashima H, Fujino Y. Central nervous system symptoms in a population of Behçet's disease patients with refractory uveitis treated with cyclosporine A. Clin Experiment Ophthalmol. 2001;29(5):335–6.
  • Kötter I, Günaydin I, Batra M, Vonthein R, Stübiger N, Fierlbeck G, Melms A. CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications–results of a retrospective analysis of 117 cases. Clin Rheumatol. 2006;25(4):482–6.
  • Akman-Demir G, Ayranci O, Kurtuncu M, Vanli EN, Mutlu M, Tugal-Tutkun I. Cyclosporine for Behçet's uveitis: is it associated with an increased risk of neurological involvement? Clin Exp Rheumatol. 2008;26(Suppl 50):S84–90.
  • Yurdakul S, Mat C, Tüzün Y, Ozyazgan Y, Hamuryudan V, Uysal O, et al. A double-blind trial of colchicine in Behçet's syndrome. Arthritis Rheum. 2001;44:2686–92.
  • Davatchi F, Sadeghi Abdollahi B, Tehrani Banihashemi A, Shahram F, Nadji A, Shams H, et al. Colchicine versus placebo in Behçet's disease: randomized, double-blind, controlled crossover trial. Mod Rheumatol. 2009;19(5):542–9.
  • Tugal-Tutkun I, Mudun A, Urgancioglu M, Kamali S, Kasapoglu E, Inanc M, Gül A. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial. Arthritis Rheum. 2005;52(8):2478–84.
  • Deuter CM, Zierhut M, Möhle A, Vonthein R, Stöbiger N, Kötter I. Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease. Arthritis Rheum. 2010;62(9):2796–805.
  • Hirano T, Ohguro N, Hohki S, Hagihara K, Shima Y, Narazaki M, et al. A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab. Mod Rheumatol. 2012;22(2):98–302.
  • Shapiro LS, Farrell J, Haghighi AB. Tocilizumab treatment for neuro-Behcet's disease, the first report. Clin Neurol Neurosurg. 2012;114(3):297–8.
  • Aramaki K, Kikuchi H, Hirohata S. HLA-B51 and cigarette smoking as risk factors for chronic progressive neurological manifestations in Behcet's disease. Mod Rheumatol. 2007;17(1):81–2.
  • Matsui T, Ishida T, Tono T, Yoshida T, Sato S-I, Hirohata S. An attack of acute neuro-Behçet's disease during the course of chronic progressive neuro-Behçet's disease: report of two cases. Mod Rheumatol. 2010;20(6):621–6.
  • Hirohata S, Suda H, Hashimoto T. Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behçet's disease. J Neurol Sci. 1998;159(2):181–5.
  • Melillo N, Sangle S, Stanford MR, Andrews TC, D’Cruz DP. Low-dose intra-venous cyclophosphamide therapy in a patient with neurological complications of Behçet's disease. Clin Rheumatol. 2007;26(8):1365–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.